Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02315742 · ClinicalTrials.gov registry record · NA

Hearts and Minds in HIV

A NA study, sponsored by Emory University.

Completed
Registry status
NA
Development phase
25
Enrollment target

NCT02315742: Completed NA study, sponsored by Emory University.

NCT02315742 is a NA study that has completed, run by Emory University. The registered enrollment target is 25 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02315742, a NA study, has completed, sponsored by Emory University.

COMPLETED
Registry status
NA
Development phase
25 participants
Enrollment target

Study Summary

The purpose of this study is to see if walking is effective for improving memory, concentration thinking abilities, physical function and quality of life of adults 50 years of age and older living with HIV.

Primary Outcome

SST is a commonly used test of response inhibition. This test consists of two parts. In the first part, the subject is introduced to the press pad, and told to press the left hand button when they see a left-pointing arrow or press the right hand button when they see a right-pointing arrow. There is one block of 16 trials for the subject to practice this. In the second part, the subject is told to continue pressing the buttons on the press pad when they see the arrows, as before, but, if they he

Interventions

  • BEHAVIORAL Let's Move Program

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2016-02
Est. Completion 2017-04
Phase NA
Emory University

1,208 total trials

What the finished NCT02315742 record still lists

NCT02315742 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which Let's Move Program is the first listed.

NCT02315742 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02315742 about?

NCT02315742 is a clinical study titled "Hearts and Minds in HIV". The purpose of this study is to see if walking is effective for improving memory, concentration thinking abilities, physical function and quality of life of adults 50 years of age and older living with HIV.

What is the current status of trial NCT02315742?

This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2016-02. Estimated completion is 2017-04.

What interventions are being tested in trial NCT02315742?

The interventions under investigation include: Let's Move Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT02315742?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02315742's enrollment target sits among peer trials

25 1712th of 2000 higher than 265 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01166854 · 25 participants

    Characterization of Familial Myopathy and Paget Disease of Bone

  • NCT01913106 · 25 participants · Phase 1

    HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer

  • NCT02138669 · 25 participants · NA

    Intacs Prescription Inserts for Keratoconus Patients

  • NCT02174549 · 25 participants · Phase 1

    Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02315742, the US trial registry maintained by the National Library of Medicine. NCT02315742 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.